ArticleJournal for immunotherapy of cancer2023

Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitination.

Zhijia Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.